GoHealth, Inc. Amends 8-K: Director Changes and Compensation

Ticker: GOCO · Form: 8-K/A · Filed: Jun 21, 2024 · CIK: 1808220

Gohealth, Inc. 8-K/A Filing Summary
FieldDetail
CompanyGohealth, Inc. (GOCO)
Form Type8-K/A
Filed DateJun 21, 2024
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.0001, $75,000 b
Sentimentneutral

Sentiment: neutral

Topics: director-change, amendment, executive-compensation

Related Tickers: GOCO

TL;DR

GOCO board shakeup: O'Malley out, Scarpino in, exec comp details updated.

AI Summary

GoHealth, Inc. filed an 8-K/A on June 21, 2024, to amend a previous filing regarding the departure of Director Patrick J. O'Malley and the election of new Director Michael J. P. Scarpino, effective June 14, 2024. The filing also addresses compensatory arrangements for certain officers.

Why It Matters

This amendment clarifies changes in the company's board of directors and potentially impacts executive compensation structures, which are key governance elements investors monitor.

Risk Assessment

Risk Level: low — This is an amendment to a previous filing, primarily clarifying director changes and compensation, which typically carries lower immediate risk.

Key Players & Entities

  • GoHealth, Inc. (company) — Registrant
  • Patrick J. O'Malley (person) — Departing Director
  • Michael J. P. Scarpino (person) — Newly Elected Director
  • June 14, 2024 (date) — Effective date of director changes
  • June 21, 2024 (date) — Filing date of the 8-K/A

FAQ

Who is the departing director from GoHealth, Inc.?

Patrick J. O'Malley is the departing director.

Who is the newly elected director at GoHealth, Inc.?

Michael J. P. Scarpino has been elected as a new director.

What is the effective date of the director changes?

The director changes are effective as of June 14, 2024.

What type of SEC filing is this amendment?

This is a Form 8-K/A, an amendment to a Current Report.

What other information does this 8-K/A filing address besides director changes?

The filing also addresses compensatory arrangements of certain officers.

Filing Stats: 555 words · 2 min read · ~2 pages · Grade level 11.4 · Accepted 2024-06-20 18:56:53

Key Financial Figures

  • $0.0001 — which registered Class A Common Stock, $0.0001 par value per share GOCO The Nasdaq Glo
  • $75,000 b — f Financial Officer consisting of (i) a $75,000 bonus payable at the time of the appointm

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. GoHealth, Inc. (Registrant) Date: June 20, 2024 By: /s/ Bradley M. Burd Brad Burd Chief Legal Officer

View Full Filing

View this 8-K/A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.